NooGut Raises to 'Deprecate the Mouth'
“The Sand Hill Road set can't stop talking about the applicator that looks like a fountain pen and charges on a slab of marble.”
Read on TechCrunched →Coverage, releases, and recognition for the company that decided the gastric barrier was optional.
“The most quietly disruptive hardware company since the smartphone — and the only one you'd be embarrassed to explain to your parents.”
Selected coverage. Outlets are fictional; the enthusiasm is aspirational.
“The Sand Hill Road set can't stop talking about the applicator that looks like a fountain pen and charges on a slab of marble.”
Read on TechCrunched →“NooGut is betting five hundred million idle neurons are the most under-provisioned asset in the human body. Investors agree.”
Read on The Enteric Journal →“By syncing WHOOP and Apple Health to a Bluetooth applicator, NooGut has made 'titration as a service' a real product category.”
Read on Bloomberg Terminal Velocity →“The company insists the molecule was never the moat. The loop is. After a week with the platform, we're inclined to believe them.”
Read on Protocol Weekly →“The Term Sheet™ bundle sold out twice. In certain group chats, owning a Disruptor™ now signals more than a Patagonia vest ever did.”
Read on Founder Fuel →“The Smart Ledger cryptographically commits every protocol. Critics call it unnecessary. NooGut calls it ownership.”
Read on The Gut Ledger →NooGut Technologies today opened the public beta of NooGutOS, its closed-loop titration platform, and outlined a roadmap toward intra-day re-titration. 'Nightly dosing was always a batch process,' said Head of Protocol Marcus Rell. 'We're closing the loop tighter.'
— For media inquiries, contact press@noogut.com
The Term Sheet™ pairs a Disruptor™ applicator, a Base Station Pro™, and a three-month Seed Round™ subscription. 'It's everything required to close your first round — on yourself,' said Founder & Chief Optimization Officer Chase Ventureborne.
— For media inquiries, contact press@noogut.com
NooGut Technologies announced the close of its Series A, led by Sphinxter Capital, to expand discreet fulfillment and harden the NOOGUT-1 evidence base beyond its current cohort. Terms were not disclosed, cryptographically or otherwise.
— For media inquiries, contact press@noogut.com
Dr. Ana Sölen, PhD in enteric neuroscience, joins NooGut to lead the research organization. 'The second brain was never a backup,' said Sölen. 'It was a roadmap.'
— For media inquiries, contact press@noogut.com
High-resolution product photography, brand marks, executive headshots, and a fact sheet that studiously avoids the word we're all thinking.